Control of Normal Tau Levels by Molecular Chaperones

Jason Gestwicki, PhD
University of California, San Francisco (San Francisco, CA)
Year Awarded:
Grant Duration:
July 1, 2015 to June 30, 2018
Alzheimer's Disease
Award Amount:
Grant Reference ID:
Award Type:
Award Region:
US Southwestern
Jason Gestwicki, PhD

Regulation Of Tau Homeostasis By Molecular Chaperones


Alzheimer’s disease is a devastating condition that impacts patients, their families and their caregivers. Since there is little in the way of treatment and as yet no cure for this disease, a major goal of our group is to pursue new and unconventional ways of preventing it. In the current project, we are trying to understand how the body’s own proteins (termed molecular chaperones) protect us against Alzheimer’s disease. At the same time, we hope to learn why this system fails during disease, so we can use this knowledge to design drugs that activate the molecular chaperones.

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.